David M Pariser

Summary

Affiliation: Eastern Virginia Medical School
Country: USA

Publications

  1. ncbi request reprint Promoting and maintaining or restoring healthy nails: practical recommendations for clinicians and patients
    David Pariser
    Eastern Virginia Medical School, Department of Dermatology, Pariser Dermatology, 601 Medical Tower, Norfolk, VA 23507, USA
    Semin Cutan Med Surg 32:S13-4. 2013
  2. doi request reprint Integrated safety analysis: short- and long-term safety profiles of etanercept in patients with psoriasis
    David M Pariser
    Eastern Virginia Medical School and Virginia Clinical Research Inc, Norfolk, Virginia, USA
    J Am Acad Dermatol 67:245-56. 2012
  3. doi request reprint Ethical considerations in health care reform: pros and cons of the Affordable Care Act
    David M Pariser
    Department of Dermatology, Eastern Virginia Medical School, 601 Medical Tower, Norfolk, VA 23507, USA
    Clin Dermatol 30:151-5. 2012
  4. ncbi request reprint Tretinoin gel microsphere pump 0.04% plus 5% benzoyl peroxide wash for treatment of acne vulgaris: morning/morning regimen is as effective and safe as morning/evening regimen
    David Pariser
    Department of Dermatology, Eastern Virginia Medical School, Virginia Clinical Research, Inc, Norfolk, VA, USA
    J Drugs Dermatol 9:805-13. 2010
  5. doi request reprint Topical corticosteroids and topical calcineurin inhibitors in the treatment of atopic dermatitis: focus on percutaneous absorption
    David Pariser
    Department of Dermatology, Eastern Virginia Medical School, 601 Medical Tower, Norfolk, VA 23507, USA
    Am J Ther 16:264-73. 2009
  6. doi request reprint Topical methyl-aminolevulinate photodynamic therapy using red light-emitting diode light for treatment of multiple actinic keratoses: A randomized, double-blind, placebo-controlled study
    David Pariser
    Eastern Virginia Medical School, Division of Dermatology and Virginia Clinical Research Inc, Norfolk, Virginia 23507, USA
    J Am Acad Dermatol 59:569-76. 2008
  7. ncbi request reprint An in-office diagnostic procedure to detect dermatophytes in a nationwide study of onychomycosis patients
    David Pariser
    Division of Dermatology, Eastern Virginia Medical School, Norfolk, VA, USA
    Manag Care 11:43-8, 50. 2002
  8. ncbi request reprint Clinical efficacy of efalizumab in patients with chronic plaque psoriasis: results from three randomized placebo-controlled Phase III trials: part I
    David M Pariser
    Department of Dermatology, Eastern Virginia Medical School, Norfolk, VA, USA
    J Cutan Med Surg 9:303-12. 2005
  9. ncbi request reprint Treating psoriasis patients with biologic agents
    David M Pariser
    Department of Dermatology, Eastern Virginia Medical School, 601 Medical Tower, Norfolk, VA 23507, USA
    Manag Care 12:50-7; discussion 57-9; quiz 60-2. 2003
  10. ncbi request reprint Calcitriol 3 microg/g ointment in the management of mild to moderate plaque type psoriasis: results from 2 placebo-controlled, multicenter, randomized double-blind, clinical studies
    Mark Lebwohl
    Department of Dermatology, Mount Sinai School of Medicine, New York, NY 10029 6574, USA
    J Drugs Dermatol 6:428-35. 2007

Detail Information

Publications34

  1. ncbi request reprint Promoting and maintaining or restoring healthy nails: practical recommendations for clinicians and patients
    David Pariser
    Eastern Virginia Medical School, Department of Dermatology, Pariser Dermatology, 601 Medical Tower, Norfolk, VA 23507, USA
    Semin Cutan Med Surg 32:S13-4. 2013
    ..This article provides a quick reference for clinicians and includes a handout for patients to support the health care provider's educational efforts...
  2. doi request reprint Integrated safety analysis: short- and long-term safety profiles of etanercept in patients with psoriasis
    David M Pariser
    Eastern Virginia Medical School and Virginia Clinical Research Inc, Norfolk, Virginia, USA
    J Am Acad Dermatol 67:245-56. 2012
    ..Multiple trials demonstrate the tolerability and safety of etanercept. However, there are limited data on etanercept tolerability in large populations of patients with psoriasis or with extended therapy...
  3. doi request reprint Ethical considerations in health care reform: pros and cons of the Affordable Care Act
    David M Pariser
    Department of Dermatology, Eastern Virginia Medical School, 601 Medical Tower, Norfolk, VA 23507, USA
    Clin Dermatol 30:151-5. 2012
    ..This contribution discusses the ethical considerations of the ACA from 3 perspectives: society, health care providers in general, and dermatologists specifically...
  4. ncbi request reprint Tretinoin gel microsphere pump 0.04% plus 5% benzoyl peroxide wash for treatment of acne vulgaris: morning/morning regimen is as effective and safe as morning/evening regimen
    David Pariser
    Department of Dermatology, Eastern Virginia Medical School, Virginia Clinical Research, Inc, Norfolk, VA, USA
    J Drugs Dermatol 9:805-13. 2010
    ..The tolerability of both regimens was comparable. The morning/morning regimen is a safe and effective treatment option for patients with moderate acne vulgaris...
  5. doi request reprint Topical corticosteroids and topical calcineurin inhibitors in the treatment of atopic dermatitis: focus on percutaneous absorption
    David Pariser
    Department of Dermatology, Eastern Virginia Medical School, 601 Medical Tower, Norfolk, VA 23507, USA
    Am J Ther 16:264-73. 2009
    ....
  6. doi request reprint Topical methyl-aminolevulinate photodynamic therapy using red light-emitting diode light for treatment of multiple actinic keratoses: A randomized, double-blind, placebo-controlled study
    David Pariser
    Eastern Virginia Medical School, Division of Dermatology and Virginia Clinical Research Inc, Norfolk, Virginia 23507, USA
    J Am Acad Dermatol 59:569-76. 2008
    ..The use of light-emitting diode light offers practical advantages in photodynamic therapy (PDT) with topical methyl-aminolevulinate (MAL) for management of actinic keratoses (AK)...
  7. ncbi request reprint An in-office diagnostic procedure to detect dermatophytes in a nationwide study of onychomycosis patients
    David Pariser
    Division of Dermatology, Eastern Virginia Medical School, Norfolk, VA, USA
    Manag Care 11:43-8, 50. 2002
    ....
  8. ncbi request reprint Clinical efficacy of efalizumab in patients with chronic plaque psoriasis: results from three randomized placebo-controlled Phase III trials: part I
    David M Pariser
    Department of Dermatology, Eastern Virginia Medical School, Norfolk, VA, USA
    J Cutan Med Surg 9:303-12. 2005
    ..Effective psoriasis therapies are needed for long-term symptom control...
  9. ncbi request reprint Treating psoriasis patients with biologic agents
    David M Pariser
    Department of Dermatology, Eastern Virginia Medical School, 601 Medical Tower, Norfolk, VA 23507, USA
    Manag Care 12:50-7; discussion 57-9; quiz 60-2. 2003
  10. ncbi request reprint Calcitriol 3 microg/g ointment in the management of mild to moderate plaque type psoriasis: results from 2 placebo-controlled, multicenter, randomized double-blind, clinical studies
    Mark Lebwohl
    Department of Dermatology, Mount Sinai School of Medicine, New York, NY 10029 6574, USA
    J Drugs Dermatol 6:428-35. 2007
    ..Calcitriol 3 microg/g ointment has demonstrated good clinical efficacy as well as topical and systemic safety when used to treat psoriasis...
  11. ncbi request reprint Long-term safety and efficacy of a unique fixed-dose combination gel of adapalene 0.1% and benzoyl peroxide 2.5% for the treatment of acne vulgaris
    David M Pariser
    Virginia Clinical Research, Inc and Eastern Virginia Medical School, Norfolk, VA 23507, USA
    J Drugs Dermatol 6:899-905. 2007
    ..A unique, once-daily, fixed-dose combination gel with adapalene 0.1% and benzoyl peroxide (BP) 2.5% has been developed for the treatment of acne vulgaris...
  12. ncbi request reprint Facial hyperhidrosis: best practice recommendations and special considerations
    Dee Anna Glaser
    Department of Dermatology, Saint Louis University, Missouri, USA
    Cutis 79:29-32. 2007
    ..Special considerations and navigating the insurance reimbursement process also are discussed...
  13. ncbi request reprint Photodynamic therapy with topical methyl aminolevulinate for actinic keratosis: results of a prospective randomized multicenter trial
    David M Pariser
    Division of Dermatology, Eastern Virginia Medical School, and Virginia Clinical Research Inc, Norfolk, VA, USA
    J Am Acad Dermatol 48:227-32. 2003
    ..Methyl aminolevulinate (MAL) (Metvix, PhotoCure, Oslo, Norway) leads to selective accumulation of photoactive porphyrins in premalignant skin lesions and makes the lesions susceptible to phototoxic effects on illumination with red light...
  14. ncbi request reprint Pimecrolimus cream 1%: a potential new treatment for chronic hand dermatitis
    Donald V Belsito
    Division of Dermatology, University of Kansas Medical Center, 4023 Wescoe Pavillion, Kansas City, KS 66160, USA
    Cutis 73:31-8. 2004
    ..Pimecrolimus was well tolerated, with a low rate of application-site reactions such as burning. Pimecrolimus cream 1%, when used twice daily with overnight occlusion, may be of benefit in the management of chronic HD...
  15. ncbi request reprint Onchomycosis: an overview
    Boni E Elewski
    Department of Dermatology, University of Alabama Birmingham, AL, USA
    J Drugs Dermatol 12:s96-103. 2013
    ..Hyperkeratosis occurs under the nail plate, resulting in detachment of the nail plate from the nail bed (onycholysis), with subungual thickening...
  16. ncbi request reprint Palmar and plantar hyperhidrosis: best practice recommendations and special considerations
    Dee Anna Glaser
    Department of Dermatology, Saint Louis University, Missouri, USA
    Cutis 79:18-28. 2007
    ..Insurance reimbursement for treating HH with BTX-A can be challenging; navigating the insurance reimbursement process will be discussed...
  17. ncbi request reprint Ciclopirox gel in the treatment of patients with interdigital tinea pedis
    Raza Aly
    Department of Dermatology, University of California San Francisco, USA
    Int J Dermatol 42:29-35. 2003
    ..Ciclopirox, a broad-spectrum hydroxypyridone antifungal, has proven efficacy against the organisms commonly implicated in tinea pedis; Trichophyton rubrum, T.mentagrophytes and Epidermophyton floccosum...
  18. ncbi request reprint From the Medical Board of the National Psoriasis Foundation: monitoring and vaccinations in patients treated with biologics for psoriasis
    Mark Lebwohl
    Department of Dermatology, Mount Sinai School of Medicine, New York, New York, USA
    J Am Acad Dermatol 58:94-105. 2008
    ..Biologics are widely used in the treatment of psoriasis and psoriatic arthritis...
  19. doi request reprint Efinaconazole 10% solution in the treatment of toenail onychomycosis: Two phase III multicenter, randomized, double-blind studies
    Boni E Elewski
    Department of Dermatology, University of Alabama at Birmingham School of Medicine, Birmingham, Alabama 35294 0009, USA
    J Am Acad Dermatol 68:600-8. 2013
    ..Topical lacquer treatments have negligible efficacy. Oral treatments, although more efficacious, are limited by drug interactions and potential hepatotoxicity...
  20. ncbi request reprint A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial
    Boni E Elewski
    Department of Dermatology, University of Alabama at Birmingham, 35233, USA
    Arch Dermatol 139:1444-50. 2003
    ..75% metronidazole gel (MetroGel; Galderma Laboratories LP, Fort Worth, Tex) as topical therapy for moderate, papulopustular facial rosacea...
  21. ncbi request reprint The efficacy and safety of adapalene gel 0.3% in the treatment of acne vulgaris: A randomized, multicenter, investigator-blinded, controlled comparison study versus adapalene gel 0.1% and vehicle
    David M Pariser
    Virginia Clinical Research, Inc, Norfolk, USA
    Cutis 76:145-51. 2005
    ..The results of this study show that adapalene gel 0.3% was superior to adapalene gel 0.1% and vehicle in the treatment of moderate to moderately severe acne while retaining a similar safety and tolerability profile to adapalene 0.1% gel...
  22. ncbi request reprint Adapalene gel 0.3% for the treatment of acne vulgaris: a multicenter, randomized, double-blind, controlled, phase III trial
    Diane Thiboutot
    Department of Dermatology, Milton S Hershey Medical Center, Hershey, Pennsylvania, USA
    J Am Acad Dermatol 54:242-50. 2006
    ..A new 0.3% gel formulation of adapalene has been developed...
  23. doi request reprint Topical 0.5% ivermectin lotion for treatment of head lice
    David M Pariser
    Department of Dermatology, Eastern Virginia Medical School, Norfolk, USA
    N Engl J Med 367:1687-93. 2012
    ..There are limited data on the activity of ivermectin as a topical lousicide...
  24. ncbi request reprint National Psoriasis Foundation clinical consensus on disease severity
    David M Pariser
    Department of Dermatology, Eastern Virginia Medical School, Norfolk, VA, USA
    Arch Dermatol 143:239-42. 2007
    ....
  25. ncbi request reprint Randomized, double-blind, placebo-controlled study evaluating the lidocaine/tetracaine patch for induction of local anesthesia prior to minor dermatologic procedures in geriatric patients
    Amy K Schecter
    Department of Dermatology, Brown Medical School, Providence, Rhode Island, USA
    Dermatol Surg 31:287-91. 2005
    ..Topical anesthetics offer a noninvasive method of anesthesia...
  26. ncbi request reprint The age of biologics: we've never seen anything like this
    David M Pariser
    Department of Dermatology, Eastern Virginia Medical School, Norfolk, VA, USA
    Manag Care 12:1 p preceding table of contents. 2003
  27. ncbi request reprint Improving the standard of care for patients with psoriasis
    David M Pariser
    Department of Dermatology, Eastern Virginia Medical School, Norfolk, VA, USA
    Manag Care 12:18-20; discussion 20-1. 2003
    ....
  28. ncbi request reprint Validation of the Dermatology Life Quality Index and the Work Productivity and Activity Impairment-Chronic Hand Dermatitis questionnaire in chronic hand dermatitis
    Margaret C Reilly
    Reilly Associates, Inc, New York, New York 10022, USA
    J Am Acad Dermatol 48:128-30. 2003
    ....
  29. ncbi request reprint Primary focal hyperhidrosis: scope of the problem
    Dee Anna Glaser
    Department of Dermatology, Saint Louis University, Missouri, USA
    Cutis 79:5-17. 2007
    ..Physicians should understand the impact of focal HH and the need to stay abreast of the available treatment options to provide the best care for patients...
  30. ncbi request reprint Management of moderate to severe plaque psoriasis with biologic therapy
    David M Pariser
    Manag Care 12:36-44. 2003
  31. ncbi request reprint Transitioning patients from efalizumab to alternative psoriasis therapies: findings from an open-label, multicenter, Phase IIIb study
    Alan Menter
    Baylor University Medical Center, Dallas, Texas, USA
    Int J Dermatol 46:637-48. 2007
    ..To prevent rebound on discontinuation of efalizumab, this study evaluated the effectiveness of transitioning patients to an alternative psoriasis therapy...
  32. ncbi request reprint The use of photodynamic therapy in dermatology: results of a consensus conference
    Mark S Nestor
    Center for Cosmetic Advancement, Aventura, FL, USA
    J Drugs Dermatol 5:140-54. 2006
    ..Appropriate light sources are available in many dermatology offices. The expanding clinical and financial benefits of PDT justify the purchase of an appropriate light source...
  33. ncbi request reprint AAD consensus statement on psoriasis therapies
    Jeffrey P Callen
    J Am Acad Dermatol 49:897-9. 2003
  34. ncbi request reprint Tacrolimus ointment is safe and effective in the treatment of atopic dermatitis: results in 8000 patients
    John Y M Koo
    University of California San Francisco Psoriasis and Skin Treatment Center, San Francisco, California, USA
    J Am Acad Dermatol 53:S195-205. 2005
    ..We sought to evaluate the safety and efficacy of tacrolimus ointment in a large cohort of adult and pediatric patients with atopic dermatitis (AD)...